Cargando…

Serum prolidase activity in benign joint hypermobility syndrome

BACKGROUND: Moderate joint laxity is widespread in many joints of the body, and this condition is considered to be caused by an abnormality in the collagen structure. This study was carried out to determine the serum prolidase activity in female patients with benign joint hypermobility syndrome (BJH...

Descripción completa

Detalles Bibliográficos
Autores principales: Em, Serda, Ucar, Demet, Oktayoglu, Pelin, Bozkurt, Mehtap, Caglayan, Mehmet, Yıldız, Ismail, Evliyaoglu, Osman, Nas, Kemal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995801/
https://www.ncbi.nlm.nih.gov/pubmed/24612543
http://dx.doi.org/10.1186/1471-2474-15-75
_version_ 1782312939931303936
author Em, Serda
Ucar, Demet
Oktayoglu, Pelin
Bozkurt, Mehtap
Caglayan, Mehmet
Yıldız, Ismail
Evliyaoglu, Osman
Nas, Kemal
author_facet Em, Serda
Ucar, Demet
Oktayoglu, Pelin
Bozkurt, Mehtap
Caglayan, Mehmet
Yıldız, Ismail
Evliyaoglu, Osman
Nas, Kemal
author_sort Em, Serda
collection PubMed
description BACKGROUND: Moderate joint laxity is widespread in many joints of the body, and this condition is considered to be caused by an abnormality in the collagen structure. This study was carried out to determine the serum prolidase activity in female patients with benign joint hypermobility syndrome (BJHS), and to evaluate its correlation with their clinical features. METHODS: A total of 45 patients with BJHS and 40 healthy controls were included in the study. All of the patients with BJHS met the Beighton diagnostic criteria. All the patients and the control group underwent a comprehensive examination of the locomotor system and took the New York Posture Rating Test. The examination and test results were recorded. Serum prolidase activity was measured in both the groups. RESULTS: Prolidase activity was significantly lower in patients with BJHS (479.52 ± 126.50) compared to the healthy controls (555.97 ± 128.77) (p = 0.007). We found no correlation between serum prolidase activity and Beighton scores or New York rating test scores. On the other hand, mean prolidase activity was significantly lower in patients with pes planus or hyperlordosis compared to those without (p = 0.05, p = 0.03, respectively). We did not find such a correlation with the other clinical features. CONCLUSIONS: Significantly lower prolidase activity in patients with BJHS suggests that prolidase may affect the collagen metabolism and cause hyperlaxity.
format Online
Article
Text
id pubmed-3995801
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39958012014-04-23 Serum prolidase activity in benign joint hypermobility syndrome Em, Serda Ucar, Demet Oktayoglu, Pelin Bozkurt, Mehtap Caglayan, Mehmet Yıldız, Ismail Evliyaoglu, Osman Nas, Kemal BMC Musculoskelet Disord Research Article BACKGROUND: Moderate joint laxity is widespread in many joints of the body, and this condition is considered to be caused by an abnormality in the collagen structure. This study was carried out to determine the serum prolidase activity in female patients with benign joint hypermobility syndrome (BJHS), and to evaluate its correlation with their clinical features. METHODS: A total of 45 patients with BJHS and 40 healthy controls were included in the study. All of the patients with BJHS met the Beighton diagnostic criteria. All the patients and the control group underwent a comprehensive examination of the locomotor system and took the New York Posture Rating Test. The examination and test results were recorded. Serum prolidase activity was measured in both the groups. RESULTS: Prolidase activity was significantly lower in patients with BJHS (479.52 ± 126.50) compared to the healthy controls (555.97 ± 128.77) (p = 0.007). We found no correlation between serum prolidase activity and Beighton scores or New York rating test scores. On the other hand, mean prolidase activity was significantly lower in patients with pes planus or hyperlordosis compared to those without (p = 0.05, p = 0.03, respectively). We did not find such a correlation with the other clinical features. CONCLUSIONS: Significantly lower prolidase activity in patients with BJHS suggests that prolidase may affect the collagen metabolism and cause hyperlaxity. BioMed Central 2014-03-11 /pmc/articles/PMC3995801/ /pubmed/24612543 http://dx.doi.org/10.1186/1471-2474-15-75 Text en Copyright © 2014 Em et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
spellingShingle Research Article
Em, Serda
Ucar, Demet
Oktayoglu, Pelin
Bozkurt, Mehtap
Caglayan, Mehmet
Yıldız, Ismail
Evliyaoglu, Osman
Nas, Kemal
Serum prolidase activity in benign joint hypermobility syndrome
title Serum prolidase activity in benign joint hypermobility syndrome
title_full Serum prolidase activity in benign joint hypermobility syndrome
title_fullStr Serum prolidase activity in benign joint hypermobility syndrome
title_full_unstemmed Serum prolidase activity in benign joint hypermobility syndrome
title_short Serum prolidase activity in benign joint hypermobility syndrome
title_sort serum prolidase activity in benign joint hypermobility syndrome
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995801/
https://www.ncbi.nlm.nih.gov/pubmed/24612543
http://dx.doi.org/10.1186/1471-2474-15-75
work_keys_str_mv AT emserda serumprolidaseactivityinbenignjointhypermobilitysyndrome
AT ucardemet serumprolidaseactivityinbenignjointhypermobilitysyndrome
AT oktayoglupelin serumprolidaseactivityinbenignjointhypermobilitysyndrome
AT bozkurtmehtap serumprolidaseactivityinbenignjointhypermobilitysyndrome
AT caglayanmehmet serumprolidaseactivityinbenignjointhypermobilitysyndrome
AT yıldızismail serumprolidaseactivityinbenignjointhypermobilitysyndrome
AT evliyaogluosman serumprolidaseactivityinbenignjointhypermobilitysyndrome
AT naskemal serumprolidaseactivityinbenignjointhypermobilitysyndrome